Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Ten63 Therapeutics Secures $15.9M in Series A Financing

2023-05-03
DURHAM, NC, Ten63 Therapeutics announced the closing of $15.9M in Series A financing.
Ten63 Therapeutics, is a company combining generative AI and physics-based models to develop first- and best-in-class therapeutics, announced the closing of an oversubscribed $15.9 million Series A financing led by new investor Hatteras Venture Partners. Morpheus Ventures, SOSV, Draper Associates, Alexandria Venture Investments, the Sigma Group and other new investors also participated in the round.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors